CDER therapeutic protein research
Executive Summary
FDA's Cellular, Tissue & Gene Therapies Advisory Committee will receive an update on individual research programs in the Division of Therapeutic Proteins of the Center for Drug Evaluation & Research during a May 20 teleconference. The meeting will be held between 2 p.m. and 4 p.m. A speakerphone will be available for the public at 5515 Security Lane in Rockville, Md...You may also be interested in...
Sanofi, Long-Time Leader In Diabetes, Is Exiting Diabetes Research
The company's decision to exit diabetes research is not necessarily surprising given the development and commercial challenges in the therapeutic area, but it's not insignificant either.
QUOTED. 10 December 2019. Viral Shah.
The global insulin pump market is expected to see significant growth, reaching $5.1bn by 2023. A new Market Intel story looks at the competitive landscape of the three leading companies in this market, Medtronic, Insulet and Tandem Diabetes Care, which are all expected to launch new products in 2020. See what Viral Shah, an assistant professor of medicine and pediatrics at the University of Colorado, said about the diabetes market here.
Bristol’s CAR-T Strategy Comes Into Focus With Two Near-Term Filings
In its first ASH since acquiring Celgene and with competitors coming, Bristol presented pivotal results for liso-cel (JCAR017) that support a year-end US FDA submission as bb2121 nears a first-half of 2020 filing.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: